NCT05743517 is a NA clinical trial of Fit4Treatment in Ovary Cancer, sponsored by Northwestern University.

Who is sponsoring NCT05743517?

NCT05743517 is sponsored by Northwestern University.

What drugs are being tested in NCT05743517?

Interventions in NCT05743517: Fit4Treatment.

What condition does NCT05743517 study?

NCT05743517 studies Ovary Cancer, Endometrial Cancer, Uterine Cancer, Cervical Cancer, Cervix Cancer, Vulvar Cancer, Vaginal Cancer.

Is NCT05743517 still recruiting?

NCT05743517 is currently recruiting now. Last updated 29 April 2025.

Last reviewed 2025-04-29 · How we verify

NCT05743517

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)

Recruiting now NA Last updated 29 April 2025

What this trial tests

NA trial testing Fit4Treatment in Ovary Cancer in 192 participants. Currently enrolling.

Timeline

15 September 2023

Primary endpoint
1 August 2028

1 August 2029

Quick facts

Lead sponsor	Northwestern University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	none
Primary purpose	supportive care
Enrollment	192
Start date	15 September 2023
Primary completion	1 August 2028
Estimated completion	1 August 2029
Sites	1 location across United States

Drugs / interventions tested

Fit4Treatment

Conditions studied

Ovary Cancer — all drugs for Ovary Cancer →
Endometrial Cancer — all drugs for Endometrial Cancer →
Uterine Cancer — all drugs for Uterine Cancer →
Cervical Cancer — all drugs for Cervical Cancer →

Sponsor

Northwestern University

Who can join

60 and older, female only, with Ovary Cancer or Endometrial Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary purpose of the study is to determine which of four components (symptom-burden tailored app, exercise partner, oncology provider engagement, coaching) added to a core intervention of a wearable activity tracker and commercially available app, will improve physical activity. The findings will generate meaningful knowledge about how to best increase physical activity in older gynecologic cancer patients receiving systemic cancer therapies to improve quality of life and cancer-specific survival.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Ovary Cancer

Currently open trials in the same condition.

NCT07096583 — An Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression During Chemotherapy for Ovarian Cancer · Phase 1, PHASE2 · active not recruiting
NCT07213193 — No-Stoma Policy in Advanced Ovarian Cancer Surgery · NA · recruiting
NCT07084168 — Multimedia Aid for Genetic Testing in Gynecologic Oncology · NA · recruiting
NCT06540729 — RC48 in Combination With AK104 and Bevacizumab in OCCC · Phase 2 · recruiting
NCT06556342 — The Efficacy and Safety of FRD001 in Ultrasound Contrast Imaging for Malignant Ovarian Masses in Women · NA · recruiting

Other Northwestern University trials

Trials by the same sponsor.

NCT06545695 — Epidermal Growth Factor Receptor Inhibition for Keratinopathies · Phase 1, PHASE2 · not yet recruiting
NCT07261657 — N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive C · EARLY_PHASE1 · not yet recruiting
NCT07392775 — ALDH2 Genetic Testing in East Asian Community · NA · not yet recruiting
NCT06886776 — Implementing A Secure Firearm Storage Program in Illinois Health Centers in Partnership With AllianceChicago and the Ill · NA · not yet recruiting
NCT07469176 — Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05743517 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Northwestern University
Last refreshed: 29 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05743517.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing